NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
HC Wainwright increased their Q3 2025 earnings estimates for shares of Atara Biotherapeutics in a report released on Tuesday, ...
Atara Biotherapeutics (ATRA) plans to cut around 50% of its workforce, just a little over a week after the FDA declined to ...
Short ATRA slightly under 8.11, target 4.38, stop loss @ 8.13 Check the time stamp on this data. Updated AI-Generated Signals ...
Atara Biotherapeutics has just announced a CRL by FDA for EBVALLO. Click here to read more about ATRA stock and why it is ...
The Aviationist on MSN8d
Airbus A320 ATRA Performs Maiden Flight After E-Scan AESA Radar ModificationThe Advanced Technology Research Aircraft is equipped with the nose of a Eurofighter to test the new E-Scan Mk1 AESA radar, ...
H.C. Wainwright analyst Robert Burns has reiterated their neutral stance on ATRA stock, giving a Hold rating on January 21.Invest with ...
GlobalData on MSN7d
Airbus’ A320 ATRA with Eurofighter nose completes first flightAirbus has completion of a first flight for German Aerospace Center's (DLR) modified Airbus A320 ATRA for the E-Scan radar ...
Zacks.com on MSN13d
ATRA Stock Down After FDA Issues CRL for Rare Blood Cancer CandidateAtara stock plunges 41% upon the FDA issuance of a CRL against its BLA for Ebvallo to treat EBV+ PTLD. The company is also facing a severe cash crunch.
Airbus has flown the Advanced Technology Research Aircraft (ATRA) flight test aircraft (FTA) that has been modified for the ...
HC Wainwright issued their FY2024 EPS estimates for Atara Biotherapeutics in a research note issued to investors on Wednesday, January 22nd. HC Wainwright analyst R. Burns forecasts that the ...
Need a break? Play the USA TODAY Daily Crossword Puzzle.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback